Cite
HARVARD Citation
Kedor, C. et al. (2016). A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjögren's syndrome. Clinical rheumatology. 35 (9), pp. 2203-2210. [Online].